Pancreatitis & Pancreatic Cancer for the ABIM Exam

Pancreatitis & Pancreatitis for the American Board of Internal Medicine Exam
Overview
  • Pancreatitis is an inflammation of the pancreas, classified into acute and chronic forms.
  • Acute pancreatitis is a reversible condition, while chronic pancreatitis leads to irreversible damage and fibrosis of the pancreas.
Acute Pancreatitis
Etiology
  • The most common causes of acute pancreatitis are:
    • Gallstones: Cause biliary obstruction and pancreatic ductal injury.
    • Alcohol abuse: Direct toxic effect on pancreatic acinar cells.
  • Other causes include:
    • Hypertriglyceridemia (>1000 mg/dL).
    • Hypercalcemia, trauma, medications (e.g., thiazides, azathioprine), infections (e.g., mumps), and post-ERCP.
Pathophysiology
  • Pancreatic enzymes (trypsin) become activated prematurely within the pancreas, leading to autodigestion, inflammation, and necrosis.
  • Severe cases involve systemic inflammatory response syndrome (SIRS), leading to multi-organ failure.
Clinical Presentation
  • Epigastric pain: Severe, constant, radiating to the back.
  • Nausea and vomiting.
  • Physical exam:
    • Epigastric tenderness.
    • Signs of hemorrhagic pancreatitis: Cullen’s sign (periumbilical ecchymosis) and Grey Turner’s sign (flank ecchymosis).
Cullen's Sign; Grey Turner's Sign
Diagnosis
  • Requires 2 out of 3 criteria:
    • Characteristic abdominal pain.
    • Serum amylase or lipase >3 times the upper limit of normal (lipase is more specific).
    • Imaging findings: CT or MRI showing pancreatic inflammation or necrosis.
  • CT abdomen with contrast: Identifies pancreatic necrosis, fluid collections, and pseudocysts.
  • Ultrasound: First-line for evaluating gallstone-induced pancreatitis.
Complications
  • Local: Necrosis, pancreatic pseudocyst, abscess.
  • Systemic: Acute respiratory distress syndrome (ARDS), acute kidney injury, shock, and multi-organ failure.
Management
  • Supportive care:
    • IV fluids: Aggressive hydration with isotonic crystalloid (e.g., lactated Ringer’s).
    • Pain control: Opioids are commonly used.
    • NPO (nil per os): Allows the pancreas to rest.
  • Antibiotics: Not routinely used unless there is evidence of infected pancreatic necrosis.
  • Gallstone pancreatitis: Requires cholecystectomy after recovery to prevent recurrence.
  • ERCP: Indicated for cholangitis or persistent biliary obstruction.
Chronic Pancreatitis
Etiology
  • Chronic pancreatitis is primarily caused by:
    • Alcohol abuse (most common in adults).
    • Cystic fibrosis (most common in children).
  • Other causes: Autoimmune pancreatitis, recurrent acute pancreatitis, and hereditary factors.
Pathophysiology
  • Chronic inflammation leads to fibrosis, ductal obstruction, and progressive loss of pancreatic exocrine and endocrine function.
Clinical Presentation
  • Chronic epigastric pain: Often radiates to the back, worsened by eating, and may be relieved by leaning forward.
  • Pancreatic insufficiency: Results in steatorrhea, fat-soluble vitamin deficiencies, and diabetes mellitus due to loss of islet cell function.
  • Weight loss: Due to malabsorption.
Diagnosis
  • Imaging:
    • CT scan or MRI: Show calcifications, pancreatic atrophy, or ductal dilation.
    • Endoscopic ultrasound (EUS): Can detect early changes.
  • Fecal elastase: A non-invasive marker of exocrine pancreatic insufficiency.
Complications
  • Pancreatic pseudocyst: Fluid collection that may become infected.
  • Pancreatic cancer: Chronic inflammation increases the risk.
Management
  • Pain control: Acetaminophen or NSAIDs, opioids for refractory pain.
  • Pancreatic enzyme supplementation: For malabsorption and steatorrhea.
  • Dietary modification: Small, frequent meals low in fat.
  • Surgical intervention: For refractory pain or complications (e.g., pseudocysts, ductal obstruction).
    • --
Pancreatic Cancer
Overview
  • Pancreatic cancer is primarily pancreatic adenocarcinoma, arising from the exocrine pancreas. It is associated with a poor prognosis due to late-stage diagnosis.
Risk Factors
  • Smoking: The most established risk factor.
  • Chronic pancreatitis: Increases the risk, particularly with hereditary causes.
  • Diabetes mellitus: Particularly new-onset diabetes in older adults.
  • Genetic syndromes: BRCA1/BRCA2 mutations, Lynch syndrome, familial pancreatitis.
  • Obesity and a diet high in fat.
Clinical Presentation
  • Painless jaundice: Due to obstruction of the common bile duct by a tumor in the pancreatic head.
  • Weight loss, anorexia, fatigue.
  • Abdominal pain: Vague and epigastric, often radiating to the back.
  • New-onset diabetes: Particularly in older adults without prior risk factors.
  • Courvoisier’s sign: Palpable, non-tender gallbladder in the presence of jaundice.
Diagnosis
  • CT scan with contrast: The preferred initial test to evaluate the pancreas, detect masses, and assess for metastasis.
  • Endoscopic ultrasound (EUS): Used for obtaining biopsies and staging.
  • CA 19-9: A tumor marker that can aid in diagnosis and monitor treatment response but is not specific for pancreatic cancer.
  • ERCP: Can be used to relieve biliary obstruction with stenting.
Staging and Prognosis
  • Staging is based on the TNM system (tumor size, nodal involvement, metastasis).
  • Resectable: Tumors confined to the pancreas with no major vessel involvement.
  • Locally advanced: Tumor involvement of major vessels or adjacent organs without distant metastases.
  • Metastatic: Spread to distant organs such as the liver, lungs, or peritoneum.
  • The prognosis is poor, with a 5-year survival rate of around 10% due to the advanced stage at diagnosis.
Management
Surgical
  • Pancreaticoduodenectomy (Whipple procedure): The treatment of choice for tumors in the pancreatic head that are resectable.
  • Distal pancreatectomy: For tumors in the body or tail of the pancreas.
  • Surgery is only possible in about 20% of cases due to the late presentation of the disease.
Chemotherapy
  • Gemcitabine-based regimens are used for both resectable and unresectable disease.
  • FOLFIRINOX (combination of 5-FU, irinotecan, leucovorin, and oxaliplatin) may be used in patients with good performance status.
Palliative Care
  • Biliary stenting: For relief of jaundice in non-resectable patients.
  • Pain management: Often requires opioids due to the severity of cancer-related pain.
  • Nutritional support: Patients often suffer from cachexia and require dietary interventions.
Key Points
  • Acute pancreatitis is most commonly caused by gallstones and alcohol abuse, presenting with epigastric pain and elevated lipase levels.
  • Chronic pancreatitis leads to irreversible pancreatic damage, resulting in steatorrhea, diabetes, and chronic pain.
  • Pancreatic cancer often presents late with painless jaundice, weight loss, and abdominal pain, leading to a poor prognosis.
  • CT scan is the primary diagnostic tool for both pancreatitis and pancreatic cancer.
  • Surgical resection (Whipple procedure) is the only curative treatment for pancreatic cancer but is feasible in only a minority of patients due to late-stage detection.